Myelosuppression

Search with Google Search with Bing
Information
Disease name
Myelosuppression
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT02692742 Completed Phase 2 Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia March 2016 November 2017
NCT00151866 Completed Phase 3 Efficacy of Transfusions With Platelets Stored in Platelet Additive Solution II Versus Plasma October 2003 May 2005
NCT05442177 Completed Clinical Observation of Integrated Chinese Medicine With Western Medicine for the Reduction of Chemotherapy-induced Hematologic Toxicity July 1, 2015 June 30, 2016
NCT05780294 Not yet recruiting Phase 3 A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC April 1, 2023 December 1, 2029
NCT02375334 Terminated Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy February 2015 January 2017
NCT03126890 Unknown status Investigation of the Correlation Between Plasma Concentration of Linezolid Antibiotic and Treatment Response and Adverse Reactions November 1, 2016 December 31, 2023
NCT03846414 Unknown status Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia February 13, 2019 October 1, 2020
NCT04905329 Unknown status A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer Populations April 28, 2020 September 1, 2023
NCT00524797 Unknown status N/A Profonycia - Honey for Improving Quality of Patient's Life Receiving Chemotherapy September 2007